Nazratun Noor Maria
Research Subjects
Nazratun Noor Maria has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Nusrat Jahan
University of Sciences & Technology Chittagong (USTC)
5 shared publications - Sajeda Akter
Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh, cu.ac.bd
2 shared publications - Saurav Singha
Department of Pharmacy University of Chittagong Chattogram Bangladesh
2 shared publications - Tanveer Ahsan
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
2 shared publications - Ummah Tasnim Nisat
Department of Pharmacy, University of Science and Technology Chittagong, Chattogram, Bangladesh, ustc.ac.bd
2 shared publications - Adnan Shahriar Chowdhury1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (11)
Neuropharmacological Evaluation of Amaranthus blitum Leaf Extract in Mice: Sedative, Anxiolytic-like, Antidepressant-like and Cognition-Related Behavioural Effects
Objectives: Amaranthus blitum L. (Amaranthaceae) is a widely consumed leafy vegetables with diverse pharmacological activities; however, its central nervous system effects remain under-explored. The study aimed to evaluate the neuropharmacological potential of the methanolic extract of A. blitum leaves (MEAB) using validated in vivo models in mice. Methods: Mice were orally administered MEAB (100, 200, and 400 mg/kg) and subjected to a series of behavioral tests, including open field, hole-cross, elevated plus maze (EPM), light–dark box, hole-board, forced swimming test (FST), tail suspension test (TST), social interaction, and Y-maze tests. Results: MEAB produced significant, dose-dependent neuropharmacological effects. Locomotor activity was markedly reduced in the open field test ( p p p <0.001), indicating improved cognitive function. Conclusion: The findings suggest that MEAB possesses significant CNS-modulating effects, possibly mediated through GABAergic and monoaminergic pathways. Further studies are required to elucidate the precise molecular mechanisms.
- 16 November 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (11)
Open AccessNeuropharmacological Evaluation of Amaranthus blitum Leaf Extract in Mice: Sedative, Anxiolytic-like, Antidepressant-like and Cognition-Related Behavioural Effects
Objectives: Amaranthus blitum L. (Amaranthaceae) is a widely consumed leafy vegetables with diverse pharmacological activities; however, its central nervous system effects remain under-explored. The study aimed to evaluate the neuropharmacological potential of the methanolic extract of A. blitum leaves (MEAB) using validated in vivo models in mice. Methods: Mice were orally administered MEAB (100, 200, and 400 mg/kg) and subjected to a series of behavioral tests, including open field, hole-cross, elevated plus maze (EPM), light–dark box, hole-board, forced swimming test (FST), tail suspension test (TST), social interaction, and Y-maze tests. Results: MEAB produced significant, dose-dependent neuropharmacological effects. Locomotor activity was markedly reduced in the open field test ( p p p <0.001), indicating improved cognitive function. Conclusion: The findings suggest that MEAB possesses significant CNS-modulating effects, possibly mediated through GABAergic and monoaminergic pathways. Further studies are required to elucidate the precise molecular mechanisms.
- Open Access
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Protective Effects of Mussaenda pubescens Leaf Extracts Against Oxidative Stress and Dyslipidemia
Objective: Mussaenda pubescens (Rubiaceae) is a medicinal plant, traditionally utilized for gastrointestinal, febrile, and reproductive ailments. This study was aimed at analyzing the antioxidant capacity and antihyperlipidemic efficacy of the methanolic extract of M. pubescens in a high‐cholesterol diet‐induced hyperlipidemic mouse model. Methods: Twenty‐five Swiss albino mice were randomly subdivided into five groups of five mice each: normal control, disease control, atorvastatin (20 mg/kg), 200 mg/kg of the extract, and 400 mg/kg of the extract. Hyperlipidemia was achieved by feeding a high‐fat diet for 28 days before the oral treatment was given for 12 consecutive days. The serum lipid profile and DPPH radical scavenging activity were then analyzed. Results: The extract improved the lipid abnormalities when compared with untreated hyperlipidemic mice ( p < 0.05). At 200 mg/kg, LDL‐C decreased to 11.25 ± 1.05 mg/dL, whereas the 400 mg/kg dose reduced TG and VLDL‐C to 140.50 ± 6.50 and 28.10 ± 1.30 mg/dL, respectively. Atorvastatin demonstrated greater lipid normalization. The antioxidant activity was also shown by the extract with a DPPH assay, with an IC 50 value of 235.64 μ g/mL. Conclusion: The methanolic extract of M. pubescens exhibits potent antihyperlipidemic and antioxidant activities, validating its potential as a promising phytotherapeutic candidate for the management of hyperlipidemia and oxidative stress–associated metabolic disorders. Further in‐depth phytochemical profiling and mechanistic studies are required for better evaluation of this extract.
- 1 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Open AccessProtective Effects of Mussaenda pubescens Leaf Extracts Against Oxidative Stress and Dyslipidemia
Objective: Mussaenda pubescens (Rubiaceae) is a medicinal plant, traditionally utilized for gastrointestinal, febrile, and reproductive ailments. This study was aimed at analyzing the antioxidant capacity and antihyperlipidemic efficacy of the methanolic extract of M. pubescens in a high‐cholesterol diet‐induced hyperlipidemic mouse model. Methods: Twenty‐five Swiss albino mice were randomly subdivided into five groups of five mice each: normal control, disease control, atorvastatin (20 mg/kg), 200 mg/kg of the extract, and 400 mg/kg of the extract. Hyperlipidemia was achieved by feeding a high‐fat diet for 28 days before the oral treatment was given for 12 consecutive days. The serum lipid profile and DPPH radical scavenging activity were then analyzed. Results: The extract improved the lipid abnormalities when compared with untreated hyperlipidemic mice ( p < 0.05). At 200 mg/kg, LDL‐C decreased to 11.25 ± 1.05 mg/dL, whereas the 400 mg/kg dose reduced TG and VLDL‐C to 140.50 ± 6.50 and 28.10 ± 1.30 mg/dL, respectively. Atorvastatin demonstrated greater lipid normalization. The antioxidant activity was also shown by the extract with a DPPH assay, with an IC 50 value of 235.64 μ g/mL. Conclusion: The methanolic extract of M. pubescens exhibits potent antihyperlipidemic and antioxidant activities, validating its potential as a promising phytotherapeutic candidate for the management of hyperlipidemia and oxidative stress–associated metabolic disorders. Further in‐depth phytochemical profiling and mechanistic studies are required for better evaluation of this extract.
- Open Access
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Antianemic Potential of Artocarpus chaplasha Seeds in Phenyl Hydrazine–Induced Hemolytic Anemia: Evidence From Swiss Albino Mice and Molecular Docking Studies
Background and Aim: Anemia affects billions, primarily young women and men. Taking steroids and immunosuppressants might cause side effects. So recent studies are focusing on natural hematinic agents to cure anemia. This study examined Artocarpus chaplasha seeds against phenyl hydrazine–induced hemolytic anemia in Swiss albino mice. Methods: To induce anemia, mice administered 60 mg/kg phenyl hydrazine intraperitoneally for 2 days. On Day 3, decreased RBC, hemoglobin, and hematocrit levels revealed anemia. Mice were orally treated with A. chaplasha seed methanol extract. Vitamin B 12 was the reference standard. Post 200 and 400 mg/kg test extract administration, blood was taken for hematological analysis on Day 15. All in vivo results were analyzed and supported through in silico approach. Results: Compared to positive control group, A. chaplasha seeds doses of 200 and 400 mg/kg significantly ( ∗∗ p < 0.01) increased RBC levels. Hemoglobin levels considerably increased with 200 mg/kg ( ∗ p < 0.05) and 400 mg/kg ( ∗∗ p < 0.01). The 200 and 400 mg/kg doses significantly elevated hematocrit (PCV) levels ( ∗ p < 0.05 and ∗∗∗ p < 0.001). Furthermore, in silico molecular docking studies showed significant binding affinity of the compounds against the receptor protein (PDB ID: 2HHB). With −7.2 kcal/mol, neophytadiene bound strongly. Conclusion: The in vivo activity demonstrate increase in the RBC level, and docking score shows comparability to the positive control, folinic acid with a score of −6.9 kcal/mol. Thus, the A. chaplasha seed may be a promising natural anemic treatment.
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Open AccessAntianemic Potential of Artocarpus chaplasha Seeds in Phenyl Hydrazine–Induced Hemolytic Anemia: Evidence From Swiss Albino Mice and Molecular Docking Studies
Background and Aim: Anemia affects billions, primarily young women and men. Taking steroids and immunosuppressants might cause side effects. So recent studies are focusing on natural hematinic agents to cure anemia. This study examined Artocarpus chaplasha seeds against phenyl hydrazine–induced hemolytic anemia in Swiss albino mice. Methods: To induce anemia, mice administered 60 mg/kg phenyl hydrazine intraperitoneally for 2 days. On Day 3, decreased RBC, hemoglobin, and hematocrit levels revealed anemia. Mice were orally treated with A. chaplasha seed methanol extract. Vitamin B 12 was the reference standard. Post 200 and 400 mg/kg test extract administration, blood was taken for hematological analysis on Day 15. All in vivo results were analyzed and supported through in silico approach. Results: Compared to positive control group, A. chaplasha seeds doses of 200 and 400 mg/kg significantly ( ∗∗ p < 0.01) increased RBC levels. Hemoglobin levels considerably increased with 200 mg/kg ( ∗ p < 0.05) and 400 mg/kg ( ∗∗ p < 0.01). The 200 and 400 mg/kg doses significantly elevated hematocrit (PCV) levels ( ∗ p < 0.05 and ∗∗∗ p < 0.001). Furthermore, in silico molecular docking studies showed significant binding affinity of the compounds against the receptor protein (PDB ID: 2HHB). With −7.2 kcal/mol, neophytadiene bound strongly. Conclusion: The in vivo activity demonstrate increase in the RBC level, and docking score shows comparability to the positive control, folinic acid with a score of −6.9 kcal/mol. Thus, the A. chaplasha seed may be a promising natural anemic treatment.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Antipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Open AccessAntipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- Open Access
- 30 December 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (1) , e4631
Investigation on Anti‐Diarrheal and Antipyretic Activities of citrus maxima Seeds in Swiss Albino Mice Model
In the Rutaceae family Citrus maxima is the biggest among all fruits, tradtionally used for several purposes due to its diverse ethnomedicinal, phytochemical, and pharmacological activities. Different portions of this plant have been used as sedatives and anti‐inflammatory medications, as well as to treat coughs, fevers, asthma, diarrhea, ulcers, and diabetes. There is a scientific potential for the methanolic seed extract to contain bioactive compounds, similar to those found in other parts of the plant. The extract derived from the seeds has already demonstrated potential biological activity. Moreover, there weren't many in vivo and in vitro research works on these plants' seeds. Therefore, the current research work was undertaken to analyze anti‐diarrheal and antipyretic potentials of the methanolic extract of Citrus maxima seeds (MCM). To evaluate MCM's effectiveness in treating diarrhea, castor oil‐induced diarrhea model was utilized as an evaluating method. The antipyretic effect in mice was measured using brewer's yeast induced pyrexia model. The MCM at 200 and 400 mg/kg doses markedly reduced hyperpyrexia, induced by yeast. The effect remained persistent up to 4th hour after administration. In the castor oil induced diarrhea model, the methanolic seed extract showed high level of dose dependent inhibition of diarrhea for 4 h following castor oil administration. Further investigation is necessary to elucidate and clarify the specific causative agents responsible for the dose‐dependent effects observed. The findings of the present study suggest that MCM seed extract may represent a promising alternative for the development of innovative anti‐diarrheal and anti‐pyretic compounds.
- 30 December 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (1) , e4631
Open AccessInvestigation on Anti‐Diarrheal and Antipyretic Activities of citrus maxima Seeds in Swiss Albino Mice Model
In the Rutaceae family Citrus maxima is the biggest among all fruits, tradtionally used for several purposes due to its diverse ethnomedicinal, phytochemical, and pharmacological activities. Different portions of this plant have been used as sedatives and anti‐inflammatory medications, as well as to treat coughs, fevers, asthma, diarrhea, ulcers, and diabetes. There is a scientific potential for the methanolic seed extract to contain bioactive compounds, similar to those found in other parts of the plant. The extract derived from the seeds has already demonstrated potential biological activity. Moreover, there weren't many in vivo and in vitro research works on these plants' seeds. Therefore, the current research work was undertaken to analyze anti‐diarrheal and antipyretic potentials of the methanolic extract of Citrus maxima seeds (MCM). To evaluate MCM's effectiveness in treating diarrhea, castor oil‐induced diarrhea model was utilized as an evaluating method. The antipyretic effect in mice was measured using brewer's yeast induced pyrexia model. The MCM at 200 and 400 mg/kg doses markedly reduced hyperpyrexia, induced by yeast. The effect remained persistent up to 4th hour after administration. In the castor oil induced diarrhea model, the methanolic seed extract showed high level of dose dependent inhibition of diarrhea for 4 h following castor oil administration. Further investigation is necessary to elucidate and clarify the specific causative agents responsible for the dose‐dependent effects observed. The findings of the present study suggest that MCM seed extract may represent a promising alternative for the development of innovative anti‐diarrheal and anti‐pyretic compounds.